1st Annual UCLA State-of-the-Art in Neuro-Oncology Part 1 Primary Brain Tumors Saturday, August 22, 2015 Tamkin Auditorium Ronald Reagan UCLA Medical Center Los Angeles, California
Course Description The Brain Tumor Center at UCLA presents its inaugural 2-parts comprehensive continuing medical education (CME) program that will provide updates on emergent diagnostic and treatment modalities for the management of Brain tumors from experts at the David Geffen School of Medicine at UCLA. The 1st part of this course will focus on the diagnosis and management of patients with Primary Brain Tumor and will feature faculty from Neurosurgery, Neuro-Oncology, Radiation Oncology, Neuroradiology, Neuropathology and Endocrinology. The program will provide didactic sessions on the latest advances in diagnosis and treatment of Primary Brain Tumors. Each tumor specific didactic session would then be followed by case-based presentations to demonstrate the multidisciplinary approach of a Brain Tumor Board to personalize care for patients with Primary Brain Tumors. This format will also encourage and ensure audience participation in discussion of the cases. The 2nd part of this course will focus on the diagnosis and management of patients with Metastatic Brain Tumors, which will occur later this year. Required CME on Pain Management and the Appropriate Treatment of the Terminally Ill Most California-licensed physicians are required to take, as a one-time requirement, 12 hours of CME on pain management and the appropriate care and treatment of the terminally ill. This course includes content that will satisfy up to one hour toward this requirement. Course Objectives At the conclusion of this course, participants should be better able to: Recommend the most recent diagnostic, surgical, and pathological advances in the evaluation of patients with brain tumors Understand standard and emerging treatments for patients with brain tumors and the molecular basis of these treatments Manage symptoms and complications in patients with brain tumors Target Audience This course is targeted towards Neurosurgeons, Medical Oncologists, Neurologists, Alliedhealth professionals, Neurosurgery, Neurology, and Oncology residents and fellows.
Faculty COURSE DIRECTORS Timothy Cloughesy, MD Co-Director, UCLA Brain Tumor Center Director, UCLA Neuro-Oncology Program Co-Director, Henry F. Singleton Brain Cancer Research Program Professor of Clinical Neurology* Department of Neurology P. Leia Nghiemphu, MD Director of Operations, UCLA Brain Tumor Center Director of Neuro-Oncology Clinical Services, UCLA Neuro-Oncology Program Associate Clinical Professor* Department of Neurology Linda M. Liau, MD, PhD Co-Director, UCLA Brain Tumor Center Director, UCLA Brain Tumor Program Professor & Vice Chair of Research* UCLA Department of Neurosurgery COURSE FACULTY Marvin Bergsneider, MD Director, UCLA Adult Hydrocephalus Center Co-Director, UCLA Benign Skullbase & Pituitary Tumor Program Co-Director, UCLA Neuroendoscopy Program Professor In Residence and Co-Vice Chair of Clinical Affairs* Department of Neurosurgery Robert Chin, MD, PhD Assistant Clinical Professor* Department of Radiation Oncology Tom Belle Davidson, MD Director, UCLA Pediatric Neuro-Oncology and Neural Tumors Center Assistant Professor* Department of Pediatric Hematology- Oncology Mattel Children s Hospital UCLA Aria Fallah, MD, MSc, FRCSC Assistant Professor of Neurosurgery* Mattel Children s Hospital UCLA Anthony Heaney, MD, PhD Co-Chief, UCLA Division of Endocrinology Professor, Departments of Medicine & Neurosurgery* Co-Director, UCLA Pituitary Tumor Program Tania B. Kaprealian, MD Assistant Clinical Professor* Chief of CNS Service Department of Radiation Oncology Albert Lai, MD, PhD Associate Professor-In-Residence* Department of Neurology UCLA Neuro-Oncology Program Whitney B. Pope, MD, PhD Director, Brain Tumor Imaging Director, Radiology Resident Research Professor* Department of Radiology, Section of Neuroradiology Marc S. Schwartz, MD House Clinic, Neurosurgery and Huntington Medical Research Institutes Harry V. Vinters, MD, FRCPC, FCAP Chief, Section of Neuropathology Distinguished Professor of Pathology and Laboratory Medicine & Neurology* Isaac Yang, MD Neurosurgeon Assistant Professor* Director of Medical Student Education Department of Neurosurgery *David Geffen School of Medicine at UCLA
Program 7:30 Breakfast and Registration 8:30 Welcome and Introduction Timothy Cloughesy, MD, Linda M. Liau, MD, PhD, and P. Leia Nghiemphu, MD 8:45 Surgery for Gliomas Linda M. Liau, MD, PhD 9:15 GBM Timothy Cloughesy, MD 9:45 Grade II and III Gliomas Albert Lai, MD, PhD 10:30 Break Timothy Cloughesy, MD, Linda M. Liau, MD, PhD, Tania B. Kaprealian, MD, Whitney B. Pope, MD, PhD, and Harry V. Vinters, MD, FRCPC, FCAP 10:45 Pediatric Brain Tumor I Tom Belle Davidson, MD 11:15 Pediatric Brain Tumor II Aria Fallah, MD 12:00 Lunch Tom Belle Davidson, MD, Aria Fallah, MD, MSc, FRCSC, Whitney B. Pope, MD, PhD, and Harry V. Vinters, MD, FRCPC, FCAP 1:00 Imaging in Brain Tumors Whitney B. Pope, MD, PhD 1:30 Metastatic Brain Tumors General Principles Tania B. Kaprealian, MD Tania B. Kaprealian, MD, Linda M. Liau, MD, PhD, P. Leia Nghiemphu, MD, and Whitney B. Pope, MD, PhD 2:15 Brain Tumors Symptomatic Management, Pain, and Palliative Care P. Leia Nghiemphu, MD 3:15 Break
3:30 Pituitary Tumors Marvin Bergsneider, MD Marvin Bergsneider, MD, Anthony Heaney, MD, PhD, Tania B. Kaprealian, MD, Whitney B. Pope, MD, PhD, and Harry V. Vinters, MD, FRCPC, FCAP 4:15 Skull Base Tumors Marc S. Schwartz, MD 4:45 Meningiomas Marvin Bergsneider, MD 5:30 Adjourn Robert Chin, MD, PhD, Whitney B. Pope, MD, PhD, Marc S. Schwartz, MD, Harry V. Vinters, MD, FRCPC, FCAP, and Isaac Yang, MD Save-the-Date 1st Annual UCLA State-of-the-Art in Neuro-Oncology Part 2 Brain and Spine Metastases: A Comprehensive, Multidisciplinary Approach December 12, 2015 NRB Auditorium, UCLA Campus Los Angeles, California
General Information Fee $100 Physicians $75 Nurses and Allied Health Professionals $25 Non Healthcare Professionals Refunds Cancellations must be received in writing by Friday, July 24, 2015 and will be subject to a $50 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided. Enrollment By Mail Use the form attached. Mail to the UCLA Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, Primary Brain Tumors Symposium, 10920 Wilshire Blvd., Ste. 1060, Los Angeles, CA 90024-6512 Online Go to www.cme.ucla.edu/courses, click on 1st Annual UCLA State-of-the-Art in Neuro- Oncology, Part 1 Primary Brain Tumors, and click on the registration information section. You may use your MasterCard, VISA, American Express or Discover card to register online. By Phone Use your American Express, MasterCard, VISA or Discover card. Call (310) 794-2620. By FAX Send the completed enrollment form with credit card information and authorizing signature. Fax (310) 794-2624. Program Location Ronald Reagan UCLA Medical Center Tamkin Auditorium 757 Westwood Plaza Los Angeles, CA 90095 Directions From the 405 freeway, exit Wilshire Blvd., east toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. The Ronald Reagan UCLA Medical Center is located on the corner of Westwood Plaza and Charles E. Young Dr. South. Parking Please park in lot 8. A Parking attendant will be on duty from 7:00-9:00AM. If you arrive outside of this time frame, please report to the parking kiosk on Westwood Plaza to pay for your parking permit. Participants are to pay their own parking charges at a rate of $12 per vehicle. Accreditation The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Disclosure Statement The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is truly independent and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program s participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.
1st Annual UCLA State-of-the-Art in Neuro-Oncology Part 1 Primary Brain Tumors Saturday, August 22, 2015 Mail Application for Enrollment Course Title and Number Amount 1st Annual UCLA State-of-the-Art in Neuro-Oncology M156-12 Part 1 Primary Brain Tumors Registration Fees: u $100 Physicians u $75 Nurses and Allied Health Professionals u $25 Non Healthcare Professionals Please print clearly, and remember to include your credit card number and authorizing signature. Last four digits of your Social Security Number Name (First/Middle/Last) Degree u Male u Female Preferred Mailing Address ( ) City/State/ZIP Area Code Daytime Phone ( ) Area Code FAX E-mail Specialty u Check enclosed payable to: The Regents of the University of California Charge: u MasterCard u Visa u Discover u American Express Name of cardholder Authorizing Signature Expiration (Mo/Yr) Mail to: Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, Primary Brain Tumors Symposium, 10920 Wilshire Blvd., Suite 1060, Los Angeles, CA 90024-6512.
UCLA Office of Continuing Medical Education David Geffen School of Medicine at UCLA 405 Hilgard Ave, MC29 Box 956938 Los Angeles, California 90095-6938 1st Annual UCLA State-of-the- Art in Neuro-Oncology Part 1 Primary Brain Tumors Saturday, August 22, 2015 Tamkin Auditorium Ronald Reagan UCLA Medical Center Los Angeles, California Non-Profit Org. U.S. Postage PAID UCLA